NEW YORK (GenomeWeb News) — Insilicos has been awarded a grant from the National Institutes of Health in order to study a statistical methodology that can be applied to biomedical research, the company said yesterday.

The company will use the roughly $400,000 in funds from the National Institute of General Medical Sciences to continue developing a technique called Least Angle Regression, or LARS, which is used to produce stable predictions from data with a large number of dimensions.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.